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Candida albicans is an opportunistic fungal path-
ogen causing life-threatening mucosal and systemic
infections in immunocompromised humans. Using
a murine model of mucosal Candida infection, we
investigated the role of the proinflammatory cytokine
IL-1b in host defense to Candida albicans. We find
that the synthesis, processing, and release of IL-1b
in response to Candida are tightly controlled and
first require transcriptional induction, followed by
a second signal leading to caspase-1-mediated
cleavage of the pro-IL-1b cytokine. The known fungal
pattern recognition receptors TLR2 and Dectin-1
regulate IL-1b gene transcription, whereas the
NLRP3-containing proinflammatory multiprotein
complex, the NLRP3 inflammasome, controls cas-
pase-1-mediated cleavage of pro-IL-1b. Further-
more, we show that TLR2, Dectin-1, and NLRP3 are
essential for defense against dissemination of
mucosal infection and mortality in vivo. Therefore,
in addition to sensing bacterial and viral pathogens,
the NLRP3 inflammasome senses fungal pathogens
and is critical in host defense against Candida.
INTRODUCTION
Opportunistic fungi cause life-threatening infections in immuno-
compromised hosts. In healthy individuals, Candida spp. have
low pathogenicity; however, with depressed host immunity or
when changes occur in oral microbial flora, overgrowth can
occur, resulting in oropharyngeal candidiasis (OPC, also known
as thrush) or denture stomatitis (Abu-Elteen and Abu-Alteen,
1998; Daniluk et al., 2006; Figueiral et al., 2007). Candida albi-
cans is the leading cause of life-threatening fungal disease and
ranks fourth among all bloodstream and nosocomial infections
in the United States (Jarvis et al., 1995; Wisplinghoff et al., 2004).
Considerable progress has been made in recent years in our
understanding of how pathogens are recognized by the innate
immune system and how sensing translates into signaling and
transcriptional regulation of immune response genes. SeveralCelclasses of germline-encoded pattern recognition receptors
(PRRs) have now been implicated in innate defenses. These
include the Toll-like receptors (TLRs) (Takeda and Akira, 2005),
the C-type lectin receptors (CLRs) (Huysamen and Brown,
2009), the RIG-like helicases (RLRs) (Yoneyama and Fujita,
2007), cytosolic DNA sensors (Burckstummer et al., 2009; Fer-
nandes-Alnemri et al., 2009; Hornung et al., 2009; Roberts
et al., 2009; Takaoka et al., 2007), and members of the NOD-
like receptor (NLR) family (Meylan et al., 2006). Recent evidence
has implicated TLR2 and the CLR family member Dectin-1 in
fungal recognition, phagocytosis, and the induction of inflamma-
tory responses (Gantner et al., 2003; Herre et al., 2004; Kerrigan
and Brown, 2009; Rogers et al., 2005).
IL-1b is a proinflammatory cytokine released by many cell
types and is an important mediator of inflammation during infec-
tion and inflammation (Dinarello, 2002, 2005). The synthesis, pro-
cessing, and release of IL-1b are tightly controlled and require at
least two distinct stimuli. An initial microbial stimulus through
innate PRRs results in accumulation of intracellular stores of
pro-IL-1b. A second stimulus activates a multiprotein complex
containing one or more NLRs, commonly referred to as the ‘‘in-
flammasome,’’ which controls the activation of caspase-1 and
cleavage of pro-IL-1b, followed by release of the active mature
17 kDa IL-1b (Franchi et al., 2009; Meylan et al., 2006). The
NLRs consist of a C-terminal LRR domain, a central nucleo-
tide-binding oligomerization (NACHT) domain, and a variable
N-terminal protein-protein interaction domain that can be either
a CARD, Pyrin, or BIR domain (Franchi et al., 2009; Martinon and
Tschopp, 2005). The best characterized inflammasome complex
contains NLRP3, ASC (apoptosis-associated speck-like
protein), CARDINAL, and caspase-1 (Amer et al., 2006; Franchi
et al., 2006; Miao et al., 2006, 2008; Sutterwala and Flavell,
2009; Sutterwala et al., 2007). The NLRP3 inflammasome is acti-
vated bymanymicrobial stimuli, including bacterial pore-forming
toxins (Mariathasan et al., 2006; Martinon et al., 2004), by viruses
such as Sendai virus (Kanneganti et al., 2006a), influenza (Allen
et al., 2009; Ichinohe et al., 2009; Thomas et al., 2009), and
adenovirus (Muruve et al., 2008) and by endogenous danger
signals such as ATP and monosodium urate (Martinon et al.,
2006; Martinon and Tschopp, 2004). Additional activators
include indigestible particulates like silica, asbestos, alum, and
b-amyloid (Dostert et al., 2008; Eisenbarth et al., 2008; Halle
et al., 2008; Hornung et al., 2008). Although roles for IL-1a/bl Host & Microbe 5, 487–497, May 21, 2009 ª2009 Elsevier Inc. 487
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infection (Bellocchio et al., 2004; Mencacci et al., 2000; Netea
et al., 2002; Steele and Fidel, 2002; Stuyt et al., 2002, 2004;
Vonk et al., 2006), the role of NLRs and inflammasomes in host
defense to fungal pathogens has not been addressed.
Here, we investigate the role of IL-1b in host defense to
Candida albicans by using a murine model of sustained mucosal
infection. We show that TLR2 and dectin-1 control IL-1b gene
transcription, whereas NLRP3, ASC, and caspase-1 regulate
Figure 1. In Vitro IL-1b Responses to
Candida albicans Are Morphological Stage
Dependent and Blocked by Caspase-1
Inhibitor
(A) IL-1b responses of normal PBMC primed for
3 hr with LPS and then stimulated with fixed prep-
arations of C. albicans of different morphological
stages at 106/ml.
(B) Inhibition of IL-1b responses after the addition
of caspase-1-specific inhibitor, Z-YVAD-FMK.
(C) Western blot of supernatants from PBMC stim-
ulation probed with anti-IL-1b antibody.
(D) IL-1b responses of bone marrow-derived
macrophages from wild-type mice primed for
3 hr with LPS and then stimulated with C. albicans
at 106/ml.
(E and F) Western blot of supernatants from
BMDM stimulation probed with (E) anti-IL-1b anti-
body and (F) anti-caspase-1 antibody.
***p < 0.001; **p < 0.01; *p < 0.05. Error bars, ± SD.
the processing of pro-IL-1b into the
active mature 17 kDa cytokine. Impor-
tantly, we also reveal a critical role for
TLR2, as well as Dectin-1 and the
NRLP3 inflammasome, against dissemi-
nated infection and mortality in vivo.
Therefore, our results implicate the
NLRP3 inflammasome and IL-1b produc-
tion in the regulation of mucosal anti-
fungal host defenses.
RESULTS
Candida albicans Activates
a Caspase-1-Dependent IL-1b
Response, which Is Dependent
on the Morphological Stage
of the Organism
Candida spp. are dimorphic fungi that
grow as yeast or hyphal forms, depend-
ing on environmental conditions. We first
examined IL-1b production by different
morphological forms of C. albicans.
Human PBMC were exposed to
formalin-fixed preparations of C. albicans
grown to germ tube stage (exposed to
hyphal-permissive media for 2, 4, or 6
hr, respectively) or fully hyphal forms
(>24 hr growth). As shown in Figure 1A,
Candida induction of IL-1b from LPS-primed PBMC was stron-
gest in response to germ tube forms and comparable to ATP-
treated controls. Indeed, in cells that were incubated with
Candida in the presence of the specific caspase-1 inhibitor
Z-YVAD-fmk, a synthetic peptide that irreversibly and specifi-
cally inhibits caspase-1 activity, almost complete inhibition of
IL-1b release was observed (Figure 1B). Similar data were
obtained when THP-1 cells were examined (Figure S1 available
online). We also tested the presence of IL-1b in cellular488 Cell Host & Microbe 5, 487–497, May 21, 2009 ª2009 Elsevier Inc.
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IL-1b (i.e., the 17 kDmature form) could be detected in the super-
natants (Figure 1C). Similar studies were performed with mouse
bone marrow-derived macrophages (BMDM) (Figure 1D), which
showed that C. albicans-induced IL-1b release was also stron-
gest for the germ tube forms. Cleaved IL-1b could be detected
in the supernatants by western blotting (Figure 1E).
The primary function of inflammasomes is to convert inactive
pro-caspase-1 into the active, cleaved enzyme. Inflammasome
complexes assemble upon activation by an appropriate stim-
ulus, leading to the multimerization of the adaptor molecule
ASC. Subsequently, pro-caspase-1 is recruited to ASC via the
interactions of the CARD domains of ASC and caspase-1. The
induced proximity of caspase-1 leads to autocleavage of cas-
pase-1. The two resulting subunits, p10 and p20, assemble
into the active caspase-1. The activation of caspase-1 was
next examined by monitoring the cleavage status of caspase-1
in cell supernatants. To test whether Candida can directly acti-
vate the cleavage of caspase-1, we precipitated proteins from
the supernatants of BMDM exposed to C. albicans. The cas-
Figure 2. IL-1b Responses to Candida albicans
Are Dependent on TLR2 and Dectin-1
(A) Upregulation of IL-1bmRNA by qPCR of macrophages
from Tlr2/, Dect1/, and wild-type mice stimulated for
8 hr with C. albicans of different morphological stages at
106/ml.
(B) IL-1b protein levels in supernatants of macrophages
from Tlr2/, Dect1/, and wild-type mice stimulated
overnight with C. albicans of different morphological
stages at 106/ml.
(C) IL-1b responses of wild-type macrophages stimulated
O/N with LPS at 500 ng/ml, b-glucan at 10 mg/ml, or
zymosan at 1 mg/ml alone or primed for 6 hr and then
removed and stimulated for an additional 8 hr by C. albi-
cans at 106/ml.
***p < 0.001; **p < 0.01; *p < 0.05. Error bars, ± SD.
pase-1 p10 subunit could be detected in super-
natants of C. albicans treated cells (Figure 1F).
Together, these data indicate that Candida can
activate caspase-1 to release bioactive IL-1b,
suggesting that a caspase-1-activating inflam-
masome complex is being activated. Themech-
anism by which C. albicans triggers these
events is unknown.
IL-1b Gene Transcription Is Dependent
on TLR2 and Dectin-1
The CLR Dectin-1 is a receptor for fungal
b-glucan and has been shown to cooperate
with TLR2 for the transcriptional induction of
inflammatory cytokine genes in response to C.
albicans infection (Brown et al., 2002, 2003).
First, we defined the role of TLR2 and Dectin-1
in the upregulation and activation of IL-1b in
response to C albicans. Peritoneal macro-
phages from wild-type, TLR2, or Dectin-1-defi-
cient mice were stimulated with C. albicans.
As shown in Figure 2, Candida induced IL-1b
mRNA upregulation (Figure 2A) and protein release into the
supernatants (Figure 2B) from wild-type macrophages. These
responses were completely abrogated in Tlr2/ as well as
Dect1/ deficient macrophages, demonstrating the importance
of these receptors in fungal-mediated IL-1b induction. Having
established the role of Candida in the transcriptional induction
of IL-1b, we next examined whether Candida could lead to the
processing of pro-IL-1b followed by its release into superna-
tants. Macrophages were first exposed to the fungal cell wall
PAMPs, b-glucan and zymosan, or to LPS and were then stimu-
lated withC. albicans. Neither LPS, b-glucan, nor zymosan alone
were sufficient to drive IL-1b release as shown in Figure 2C. In
contrast, when macrophages were additionally treated with
C. albicans, IL-1b release was detected. Importantly, IL-1b
release was detected in cells exposed to Candida alone, and
even higher levels of IL-1b were released in cells that had been
exposed to b-glucan, zymosan, or LPS. These data indicate
that ligands that trigger TLR2 and Dectin-1 signaling cannot by
themselves elicit IL-1b processing and release. The ability of
Candida to trigger these events in both unprimed (media-treated)Cell Host & Microbe 5, 487–497, May 21, 2009 ª2009 Elsevier Inc. 489
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by NLRP3, ASC, and Caspase-1
(A) IL-1b responses of macrophages from Asc/, Nlrp3/, and wild-type
mice primed for 4 hr with 500 ng/ml LPS and then stimulated with C. albicans
at 106/ml.
(B) Western blot of supernatants from wild-type or Asc/ macrophages
probed with anti-IL-1b antibody.490 Cell Host & Microbe 5, 487–497, May 21, 2009 ª2009 Elsevier Iand primed cells indicates that Candida can elicit IL-1b gene
transcription (signal 1) and inflammasome activation (signal 2).
Candida albicans Triggers IL-1b Production
via the NLRP3 Inflammasome
To define the molecular mechanism regulating caspase-1-medi-
atedprocessingof IL-1b, wemonitored inflammasomeactivation
by Candida in LPS-primed macrophages. LPS-primed macro-
phages from wild-type mice or mice deficient in NLRP3 or ASC
were stimulated with C. albicans and IL-1b release and cleavage
examined by ELISA andwestern blotting, respectively. As shown
in Figure 3A, IL-1b responses from macrophages deficient in
NLRP3 and ASC were significantly reduced following treatment
with all stagesofC. albicans. LPS-primedmacrophages exposed
toATP inducedhigh levels of IL-1b responses inwild-typemacro-
phages as well as in macrophages lacking TLR2 or Dectin-1, but
not in macrophages deficient in ASC, NLRP3, or caspase-1
(Figures S2A and S2B), as expected. In contrast, induction of
TNF-a and KC in response to C. albicans (which are dependent
on TLR2/Dectin-1 signaling and not on the inflammasome) was
comparable between wild-type and knockout cells (Figure S2C
anddata not shown).We also examined IL-1b cleavage in cellular
supernatants by western blotting and found that the cleaved
and active form of IL-1b could be detected in supernatants from
wild-type, but not Asc/ cells (Figure 3B). We also confirmed
that Candida-induced IL-1b was dependent on caspase-1
(Figure 3C). To determine whether ATP was responsible for
IL-1b production in response to Candida, macrophages from
the ATP-gated ion channel receptor P2X7-deficient mice were
stimulated with C. albicans. No difference in Candida-induced
IL-1b responses between the P2X7R-deficient and wild-type
cells were observed. As expected, a complete abrogation of
LPS + ATP responses was seen (Figure 3D). Together, these
data show thatC. albicans is able to induce IL-1b gene transcrip-
tion in a TLR2- andDectin-1-dependentmanner and that the pro-
cessing of IL-1b is mediated by the NLRP3/ASC inflammasome.
IL-1b Controls Antifungal Immunity In Vivo
Having established the importance of TLR2, Dectin-1, and the
NLRP3 inflammasome in controlling IL-1b production in macro-
phages, we assessed whether this pathway was important
in vivo. We first examined whether C. albicans could induce
IL-1b in vivo. To this effect, we established a murine model of
mucosal infection to define the importance of IL-1b and IL-1
receptor signaling in vivo. To establish oral infection, we first
treated mice with antibiotic containing drinking water to reduce
the competing oralmicroflora. Next, a series of shallow scratches
in the stratum corneum of the dorsal surface of the tongue were
made in anesthetized mice using a sterile scalpel. Sterile PBS
was applied for 3 hr to allow the disruptions to partially heal,
and then concentrated C. albicans strain GDH2346 (NCYC
1467), originally obtained from a denture stomatitis patient at
Glasgow Dental Hospital (McCourtie and Douglas, 1984), was
(C) IL-1b responses of macrophages from Casp1/ and wild-type mice
stimulated overnight with C. albicans at 106/ml.
(D) IL-1b responses of macrophages from P2X7R/ and wild-type mice
stimulated overnight with C. albicans at 106/ml.
***p < 0.001; **p < 0.01; *p < 0.05. Error bars, ± SD.nc.
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cotton ball for 4 to 6 hr with the animals under sedation, allowing
for consistent and sustained colonization of the oral mucosa
(Figure S3). There was no difference seen in the severity of infec-
tion, as determined by clinical scores, between mice infected
with andwithout disruption of the stratumcorneum, but we found
that the additional disruption step led to more consistent infec-
tions with little variation in fungal colonization of the oral cavity
between individual mice. Although colonization of the tongue
was slightly lower in undisrupted mice as measured by fungal
culture, there was no difference in colonization of the gut (esoph-
agus, stomach, duodenum, jejunum, and ileum) or kidneys (a
marker for systemic dissemination), as shown in Figure S5.
Wild-type mice were infected and the epithelium harvested
Figure 4. Protective Role of IL-1b in
a Murine Model of Oral Infection with
Candida albicans
(A) Fold induction of IL-1b mRNA measured by
quantitative real-time PCR by oral buccal epithe-
lium after infection with C. albicans.
(B) IL-1b (pg/ml) protein production in homoge-
nized whole tongues of mice after infection with
C. albicans.
(C and D) Quantitative fungal burden of (C)
tongues and (D) kidneys of Il1r1/ and wild-type
(WT) mice after oral infection with C. albicans.
(E and F) Fungal burden of (E) tongues and (F)
kidneys of Casp1/ and WT mice after oral infec-
tion with C. albicans.
(G) Kaplan-Meier survival plots of WT, Il1r1/,
and Casp1/ mice after infection (p < 0.0001).
(H) Mean clinical severity score of Il1r1/,
Casp1/, and wild-type after 3, 7, 14, or 21 days
of infection.
***p < 0.001; **p < 0.01; *p < 0.05. Error bars, ± SD.
from the buccal surfaces for mRNA isola-
tion and protein extraction. As shown in
Figure 4, both IL-1b mRNA (Figure 4A)
and protein (Figure 4B) levels were
strongly induced in vivo in oral mucosa
by C. albicans infection.
To define the importance of IL-1b in
mucosal fungal infection, wild-type, or
IL-1 receptor-deficient mice (Il1r1/)
were infected orally withC. albicans. After
3, 7, 14, and 21 days of infection, mice
were euthanized and clinically scored.
Tongues and organs were removed
aseptically and quantitative fungal
burdens of tongues and kidneys deter-
mined. As shown in Figure 4C, fungal
colonization of the oral cavity was signifi-
cantly higher in the Il1r/mice at all time
points. Neither wild-type nor Il1r/ mice
cleared the oral infection during the study
period. In contrast to wild-type mice, the
Il1r/ mice showed dramatically higher
levels of systemic dissemination, as
measured by quantitative fungal burdens
in the kidneys, at all time points measured (Figure 4D). Survival
was also impaired in the Il1r/ mice with cumulative 63.7%
survival after 21 days compared to 97.0% in the wild-type
mice (Figure 4G). Clinical severity, as assessed by gross scores
at the experimental endpoint (Figure S3), was also significantly
higher in Il1r/ mice (Figure 4H).
Wealso investigated the roleofcaspase-1by infectingCasp1/
orwild-typemicewithC.albicans asabove. Asshown inFigure4E,
colonization of the oral cavity was similar between the Casp1/
and wild-type mice at all time points but slightly higher at 14
days. Both strains failed to clear the oral infection during the study
period. In contrast to oral colonization, theCasp1/mice showed
greatly enhanced systemic dissemination, asmeasured byquanti-
tative fungal burdens in the kidneys, with significance at 3 andCell Host & Microbe 5, 487–497, May 21, 2009 ª2009 Elsevier Inc. 491
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4F). Survival was also impaired in theCasp1/mice,with cumula-
tive 60.3% survival after 21 days compared to 97.0% in the wild-
type mice (Figure 4G). Clinical severity, as assessed by gross
scores at the experimental endpoint, was also significantly higher
in Casp1/ mice compared to wild-type mice at all time points
(Figure 4H).
The NLRP3 Inflammasome Controls Antifungal
Immunity In Vivo
BecauseASCandNLRP3control IL-1b production in response to
C. albicans inmacrophages, we next tested the importance of the
NLRP3 inflammasome complex in antifungal defense in vivo. As
shown in Figure 5A, mice deficient in ASC had higher oral coloni-
zationafter infectionwithC.albicans, asmeasuredbyquantitative
fungal burden of homogenized tongues. This correlated with
higher gross clinical scores in the Asc/ mice compared to
wild-type (Figure 5D). Also, functional ASC is required for resis-
tance to dissemination of infection, as shown in Figure 5B, with
significantly higher fungal burdens in the kidneys compared with
wild-type mice. Survival was also significantly affected in the
ASC-deficient mice compared to wild-type (Figure 5C). NLRP3-
deficient mice infected withC. albicans showed similar oral colo-
nization as compared to wild-type mice but showed enhanced
dissemination with significantly higher fungal burdens in the
kidneys at 3 and 7 days of infection. Clinical severity of infection
Figure 5. NLRP3 Inflammasome Plays a
Critical Role in Host Defense to Mucosal
Infection with Candida albicans
(A and B) Quantitative fungal burden of (A) tongues
and (B) kidneys of Asc/ and WT mice after oral
infection with C. albicans.
(C) Kaplan-Meier survival plots of WT and Asc/
mice after infection (p = 0.0002).
(D) Mean clinical severity score of Asc/ and WT
after 3, 7, 14, or 21 days of infection.
(E and F) Quantitative fungal burden of (E) tongues
and (F) kidneys of Nlrp3/ and WT mice after oral
infection with C. albicans.
(G) Mean clinical severity score of Nlrp3/ and
WT after 3 and 7 days of infection.
***p < 0.001; **p < 0.01; *p < 0.05. Error bars, ± SD.
was also worse in the NLRP3-deficient
mice (Figure 5G). We hypothesize that
systemic dissemination of C. albicans
occurs via translocation or invasion of
the fungus through the mucosa of the
small intestine, which has been demon-
strated in some models (Cole et al.,
1988). To assess the impact of the
NLRP3 inflammasome on intestinal colo-
nization, organs were harvested and
quantitatively cultured for fungal coloniza-
tion. Both Asc/ and Nlrp3/ mice
demonstrated higher fungal burdens of
the stomach, duodenum, jejunum, and
ileum at 7 days of infection compared to
wild-type mice, which appear to partially
clear infection of the small bowel (Figure S4). Together, using
a model of mucosal candidiasis, we show that activation of the
NLRP3 inflammasome by C. albicans affects colonization of the
gut, dissemination of infection, and survival in OPC.
TLR2 and Dectin-1 Control Antifungal Immunity In Vivo
Because TLR2 and Dectin-1 regulated IL-1b production in
response to C. albicans, we also determined the role of TLR2
and Dectin-1 in the murine model. As shown in Figure 6A, oral
colonizationwassimilarbetweenwild-typeandDectin-1-deficient
mice, despite higher clinical scores (Figure 6D).However, dissem-
ination of infection occurred in the Dect1/ mice (Figure 6B), as
did significantly reduced survival (Figure 6C). In TLR2-deficient
mice, both enhancedoral colonization and dissemination of infec-
tion were observed (Figures 6E and 6F). TLR2-deficient mice also
had significantly less survival and higher clinical scores than wild-
type mice. Therefore, both TLR2 and Dectin-1 play an important
role in host defense to mucosal infection with C. albicans.
TLR2, Dectin-1, and the NLRP3 Inflammasome Control
IL-1b Production In Vivo
Finally, circulating levels of IL-1b in serum from mice infected
orally with C. albicans were quantified in all of these strains.
Serum IL-1b responses to C. albicans infection were partially
reduced in Tlr2/ mice and completely abolished in Dect1/
or double Dect1/Tlr2/ mice, indicating a cooperative role for492 Cell Host & Microbe 5, 487–497, May 21, 2009 ª2009 Elsevier Inc.
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and 7C). IL-1b production was undetectable in serum from
Nlrp3/ or Asc/ mice (Figure 7B).
DISCUSSION
Oral epithelial cells respond to fungal pathogens with the release
of proinflammatory cytokines, including IL-1a/b, IL-8, TNF-a, and
Figure 6. Innate PRRs Enhance Survival
after Oral Infection with Candida albicans
(A and B) Quantitative fungal burden of (A) tongues
and (B) kidneys of Dect1/ and wild-type (WT)
mice after oral infection with C. albicans.
(C) Kaplan-Meier survival plots of WT and
Dect1/ mice after infection (p = 0.0009).
(D) Mean clinical severity score of Dect1/ and
WT after 3 or 7 days of infection.
(E and F) Quantitative fungal burden of (E) tongues
and (F) kidneys of Tlr2/ and wild-type (WT) mice
after oral infection with C. albicans.
(G) Kaplan-Meier survival plots of WT and Tlr2/
mice after infection (p = 0.0002).
(H) Mean clinical severity score of Tlr2/ and WT
after 3, 7, 14, or 21 days of infection.
***p < 0.001; **p < 0.01; *p < 0.05. Error bars, ± SD.
antimicrobial peptides such as b-defen-
sins (Dongari-Bagtzoglou and Kashleva,
2003; Dongari-Bagtzoglou et al., 2004;
Lu et al., 2006; Mostefaoui et al., 2004).
Although encoded by different genes,
IL-1a and IL-1b share highly homologous
structures and activate through the com-
mon receptor IL-1 receptor 1 (IL-1R1),
which functions as a heterodimer with
the IL-1 receptor accessory protein
(IL-1RAcP) and signals via the TIR
domain-containing adaptor molecule
MyD88 (Dinarello, 1998). Both IL-1a and
IL-1b, as well as IL-18, have been sug-
gested to play an important role in host
defense against C. albicans infections
(Bellocchio et al., 2004; Mencacci et al.,
2000; Stuyt et al., 2002, 2004; Vonk
et al., 2006), although none have direct
antifungal activity. IL-18, which is also
processed by NLRs, has been shown to
be upregulated in a caspase-1-depen-
dent manner in response to Candida
as well as mediating the development
of protective Th1 immunity (Mencacci
et al., 2000). It is likely that the NLRP3
inflammasome controls the processing
of both IL-1b and IL-18 in response to
fungal pathogens, as has been seen in
the case of other activators of this inflam-
masome (Akita et al., 1997; Fantuzzi and
Dinarello, 1999; Ghayur et al., 1997; Gu
et al., 1997; Kuida et al., 1995).
Our studies reveal that C. albicans triggers pathways leading
to the production of IL-1b. Further, we show that it acts both
(1) as an inducer of pro-IL-1b (signal 1), as determined by
measuring IL-1b mRNA levels (Figure 2) and secretion of IL-1b
in naive cells, a response that was dependent on both TLR2
and Dectin-1 and (2) as an activator of the NLRP3 inflammasome
to process pro-IL-1b (signal 2). The ability of fixed preparations
to elicit this response suggests that fungal invasion and/orCell Host & Microbe 5, 487–497, May 21, 2009 ª2009 Elsevier Inc. 493
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Infection withC. albicans Are Dependent on
TLR2, Dectin-1, and the NLRP3 Inflamma-
some
(A) IL-1b responses in serum collected from wild-
type, Nlrp3/, or Asc/ mice orally infected
with C. albicans.
(B) IL-1b responses in serum collected from orally
infectedwild-type,Tlr2/, or doubleTlr2/Dect1/
mice.
(C) IL-1b responses in serum collected from orally
infected wild-type or Dect1/mice.
***p < 0.001; *p < 0.05. Error bars, ± SD.metabolic activity are not required. We utilized killed prepara-
tions for our in vitro studies in an effort to avoid IL-1b release
due to Candida-induced cell toxicity and death (which we did
not observe in our in vitro studies). As shown previously, heat
inactivation of Candida can unmask b-glucan structures that
bind Dectin-1 (Gantner et al., 2005). To avoid this, we used
formalin fixation to kill the organism without causing artificial
exposure of b-glucans.
Our data show that both early germ tube and fully hyphal forms
of Candida are capable of inducing IL-1b release in human
PBMC and THP-1 cells. Release of cleaved functional IL-1b is
confirmed by immunoblot analysis for the 17 kDa active cyto-
kine. Moreover, release of IL-1b, cleavage of IL-1b, and cleavage
of caspase-1 were also observed in both peritoneal and bone
marrow-derived macrophages from mice. The differential ability
of the different forms ofCandida to trigger signaling is consistent
with published data on differential immune activation by different
morphological stages of fungus (Bellocchio et al., 2004; Gantner
et al., 2005). It is unclear why the studies recently published by
another group did not reveal a role for the inflammasome in the
production of IL-1b; however, there are substantial methodologi-
cal differences between the two studies (van de Veerdonk et al.,
2009). We show a profound suppression of IL-1b production
in macrophages from NLRP3-deficient, ASC-deficient, and
caspase-1-deficient mice. Most importantly, our studies using
a mucosal model of Candida challenge show a significant
phenotype in the inflammasome-deficient mice, providing
in vivo support to our in vitro findings. Altogether, these data
implicate that the inflammasome is activated and that NLRP3,
ASC, and caspase-1 mediate Candida-induced IL-1b responses
and antifungal defense both in vitro and in vivo. A recent publica-
tion using an intravenous challenge model and in vitro studies
also supports a role for NLRP3 in IL-1b responses to Candida
and is consistent with our findings (Gross et al., 2009).
Both TLR2 and dectin-1 are known to play an important role in
fungal recognition and the induction of inflammatory responses.
Dectin-1, which recognizes b-glucan in the fungal cell wall, has
been shown to mediate phagocytosis of fungal pathogens in
a partially Syk-dependent manner, depending on the cell type
studied (Herre et al., 2004; Kerrigan and Brown, 2009; Rogers
et al., 2005). Although TLR2 recognizes fungal PAMPs andmedi-
ates inflammatory responses, it is not required for phagocytosis;
macrophages lacking TLR2, TLR4, or MyD88 internalize yeast
particles normally (Gantner et al., 2003). We show that the fungal
PAMPs b-glucan and zymosan, which bind Dectin-1 and TLR2,
respectively, can prime cells for subsequent IL-1b release by494 Cell Host & Microbe 5, 487–497, May 21, 2009 ª2009 ElsevierC. albicans but by themselves are unable to elicit this response.
C. albicans can therefore elicit pro-IL-1b induction and cleavage.
This is achieved by its ability to trigger TLR2 and dectin-1 and
activate the NLRP3 inflammasome to cleave pro-IL-1b into its
biologically active form. IL-1b was induced by inactive forms of
the fungi, indicating again that neither metabolic activity nor
active invasion of cells was required. Early germ tube or hyphal
forms were generally more stimulatory than the fully hyphal
form in vitro. Therefore, it is likely that there is differential activa-
tion by C. albicans in the context of biofilms (i.e., fully hyphal
forms) that colonize the outer layers of epithelium, as compared
to yeast and early germ tube morphological forms more often
associated with extravasating or early disseminated infection
(Saville et al., 2003, 2008).
We developed a murine model of OPC in which immunosup-
pression is not required and animals develop the characteristic
white patches and epithelial ulceration seen in humans with
oral thrush. Our goal was to establish a model of sustained
mucosal colonization that would closely mimic human oropha-
ryngeal candidiasis. Histologically, the infections that we achieve
are similar to human disease (Figure S3). Our model is also
unique, as we observe low-level, chronic dissemination from
a mucosal source in susceptible strains, which has not previ-
ously been modeled.
Using this model, we have defined an essential role for IL-1b in
host defense to Candida infection. Increased fungal burdens
were seen in the tongues of IL-1 receptor-deficient mice. More-
over, dissemination or invasion of infection from the oral source
was also dependent on IL-1b, with higher kidney fungal burdens
(a marker for dissemination) and decreased survival in Il1r/
mice. Candida can also be cultured from multiple organs in
susceptible strains, including the brain, lung, liver, bowel,
stomach, and spleen (data not shown). Using this physiologically
relevant model of sustained oral infection, we also reveal the
importance of TLR2 and Dectin-1, as well as the NLRP3 inflam-
masome (caspase-1, ASC, and NLRP3), in controlling IL-1b
production, which determines resistance against dissemination
and promotes survival of the infected host.
Key questions arising from our studies are how NLRP3 senses
C. albicans and what component of the pathogen triggers the
NLRP3 inflammasome. Numerous chemically and structurally
diverse stimuli are now known to activate the NLRP3 inflamma-
some. These include pathogenic bacteria and viruses, as well as
a broad range of microbial derivatives, bacterial pore forming
toxins, small molecule immune activators, extracellular ATP,
amyloid-b, and various crystals (e.g., silica and asbestos) (HalleInc.
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2006b; Martinon et al., 2004, 2006). It remains unclear, however,
how a single signaling molecule NLRP3 can detect such a broad
range of stimuli. Because there is no evidence that all of these
ligands bind directly to NLRP3, it has been suggested that
activation is indirect. Our studies with P2X7R-deficient macro-
phages indicate that ATP release from Candida-infected cells
is not responsible for triggering NLRP3 activation. The genera-
tion of reactive oxygen species and cathepsin B release from
damaged lysosomal compartments are additional proposed
mechanisms for activation of the NLRP3 inflammasome. The
contribution of cathepsin B has been found to be specific to
NLRP3 activation by particulates such as silica and amyloid-b.
Phagocytosis and lysosomal acidification are believed to be
important for NLRP3 activation by these agents. Additional
work is needed to elucidate the role of phagocytosis, lysosomal
disintegration, and ROS generation in activation of the NLRP3
inflammasome by C. albicans.
EXPERIMENTAL PROCEDURES
Animals
Female C57BL/6 and Il1r/ mice (ages 8–12 weeks) were purchased from
Jackson Laboratories.Nlrp3/ and Asc/mice were generated byMillenium
Pharmaceuticals. Casp1/ mice were generated by R. Flavell (Yale Univer-
sity). P2X7R/mice (C57BL/6 background) were originally provided by Pfizer
Global Research and Development, Pfizer Inc. (Solle et al., 2001) and then
backcrossed into a pure C57BL/6 background for > 12 generations from
a P2X7R/mouse strain. Animals were housed in filter-covered microisolator
cages in ventilated racks. All animal studies have been approved by the Insti-
tutional Animal Care and Use Committee of Case Western Reserve University
and University of Massachusetts.
Reagents
Cells were cultured in RPMI 1640 media (HyClone) containing 10% non-HI
FCS (Atlanta Biologicals). b-glucan (isolated from Saccharomyces cerevisiae)
and Z-YVAD-fmk were purchased from CalBiochem. Zymosan was obtained
from Sigma. Macrophages were lysed using Radio-Immunoprecipitation
Assay Buffer (Pierce) containing Halt Protease Inhibitor Cocktail (Thermo
Scientific). Western blots were probed using monoclonal 3ZD anti-IL-1b anti-
body (National Cancer Institute Biological Resources Branch) and polyclonal
anti-capase-1 p10 antibody (Santa Cruz Biotechnology, Inc).
Fungal Preparations
Candida albicans strain GDH2346, clinical strain originally isolated from
a denture stomatitis patient (McCourtie and Douglas, 1984), was utilized for
all in vivo and in vitro studies. Stocks were maintained on Sabouraud Dextrose
(SD) agar at 4C.Prior to challenge in theanimalmodel, a suspensionwasmade
by transferring the fungus to SD broth (Difco) and incubating at 37C with
shaking for a period of 16–24 hr. To obtain hyphal and intermediate germ
tube forms, we grew the Candida in enriched media consisting of RPMI + 10%
fetal bovine serum (FBS) for 2, 4, or 6 hr (early,mid, or late germ tube formations)
or for 24 hr for fully hyphal forms (Figure S6). For formaldehyde fixation, the
preparations were washed in sterile PBS, fixed in 1% formaldehyde solution
for 10 min, and then washed three times in sterile PBS. After resuspension in
sterile PBS, the preps were stored at 80C until use.
Cell Isolation and Culture
Bone marrow-derived macrophages were generated as described (Severa
et al., 2006). Human PBMCs were isolated from whole blood of healthy volun-
teers by density gradient centrifugation. Lysis of red blood cells was performed
using red blood cell lysis buffer (Sigma). Experiments in PBMCs and macro-
phages were carried out at a cell density of 2 3 106 cells/ml. All primary cells
and cell lines except THP-1 cells were cultured in DMEM supplemented with
L-glutamine, ciprofloxacin (Cellgro), and 10% fetal calf serum (Hyclone).CelTHP-1 cells were cultured in RPMI supplemented with 10% fetal calf serum
(Hyclone), L-glutamine, sodium pyruvate (Cellgro), and ciprofloxacin. At
1 day prior to stimulation, THP-1 cells were differentiated using 0.5 mM PMA
for 3 hr, washed three times, and plated for stimulation. The caspase-1 inhib-
itor z-YVAD (10 mM) was added for 1 hr prior to stimulation. Thioglycollate-eli-
cited peritoneal macrophages were isolated by adherence and stimulated at
a density of 2 3 106 cells per well in a 6-well plate in RPMI 1640 (HyClone)
with 10% FCS (Atlanta Biologicals). Cells were primed with 200–500 ng/ml
low-protein LPS for 3–4 hr, followed by fixedCandida at106/ml for 8 hr. Alter-
natively, naive cells were stimulated overnight with fixed Candida prepara-
tions. Supernatants were harvested and assayed for cytokine release. Cells
were lysed in RIPA buffer and run on SDS-PAGE gel and transferred to nitro-
cellulose, followed by probing for IL-1b and caspase-1. All experiments that
were performed for western blot analysis were carried out in serum-free
DMEM medium. ATP stimulations were carried out at 5 mM 1 hr prior to har-
vesting supernatants.
Murine Model of OPC
Five days prior to challenge with C. albicans, the mice were placed on tetracy-
cline (Fisher Scientific) containing drinking water (2.5 g/l). The mice were
anesthetized i.p. with a cocktail of Ketamine (Vedco) andAcepromazine (Boeh-
ringer Ingelheim), and the dorsal surface of the tongue was lightly scratched
(limited to the superficial stratum corneum of the epithelial layer) using a sterile
#10 blade scalpel to roughen the surface. A sterile, uniform-sized cotton
packing was placed in the oral cavity and saturated with PBS to keep the
mouth moist. After 3 hr, the cotton was replaced and saturated with 100 ml of
5.03 107/ml CFUsuspension ofCandida albicans yeast in PBS and left in place
for4–6 hr while the animals remain sedated. After a 3–28 day infection period,
the mice were given a clinical score to assess the degree of oral infection
(FigureS3); the tongues andother target organswere collected aseptically after
euthanasia, weighed, and homogenized in sterile-normal saline using a Tissue-
Lyser bead-beater homogenizer (Retsch) in individual sterile nuclease-free
tubes. Serial dilutions of the homogenate (10-fold) were made in sterile PBS
and plated in triplicate onto SD agar, sealed and incubated for 48 hr at 37C,
and fungal coloniesmanually counted. Fungal burdens of the tissues are shown
as log CFU per gram of tissue (absolute fungal data is included in Table S1). To
assess inflammatory responses in the oral mucosa, buccal epithelium was
removed at necropsy by blunt dissection and placed in RNAlater (QIAGEN) or
PBS, homogenized, and frozen at -80C for mRNA isolation or protein assay,
respectively. For serumcollection, whole bloodwas obtained from retro-orbital
sinus into EDTA precoated tubes and was centrifuged, and serum was
removed and frozen.
Quantitative Real-Time PCR and Enzyme-Linked Immunosorbent
Assay
Quantitative real-time PCR was done as described (see Supplemental Exper-
imental Procedures for additional details). Cytokines were measured in culture
supernatants collected after 24 hr of stimulation by ELISA (R&D).
Western Blot Analysis
Cell culture supernatantswereprecipitated byaddinganequal volumeofmeth-
anol and 0.25 volumes of chloroform, mixed and centrifuged at 20,0003 g for
10 min. The upper phase was discarded, and 500 ml of methanol was added to
the interphase. This mixture was centrifuged at 20,000 3 g for 10 min and the
protein pellet dried at 55C, resuspended in Laemmli buffer, and boiled at
99C for 5 min. Samples were separated by SDS-PAGE (15%) and transferred
onto nitrocellulose membranes. As indicated, blots were incubated with rabbit
polyclonal antibody to anti-murine caspase-1p10 (sc-514,SantaCruzBiotech-
nology), rabbit polyclonal anti-human caspase-1 p10 (sc-515, Santa Cruz
Biotechnology), rabbit polyclonal anti-human cleaved IL-1b (Asp116) (Cell
Signaling), or rabbit polyclonal anti-murine cathepsin B (R&D Systems).
Statistical Analysis
Data were analyzed using commercial software (GraphPad Software), and
Student’s two-sample independent t test was used for statistical analysis.
Comparison of two survival curves was done using the Logrank test. P values
are presented where statistical significance was found (significance set at
p < 0.05).l Host & Microbe 5, 487–497, May 21, 2009 ª2009 Elsevier Inc. 495
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